Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06575725
Title Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST